Riyadh 11691 / Phone 0555904677
E-mail:
Dr. Khalid Abdulrahman AlSaleh
Personal Information / DOB : Oct 16,1977Education / 1994- 2000 KingSaudUniversity, College Of Medicine -Riyadh
qualification degree: MBBS
- I graduated with overall average: Very good with second honor degree.
Internship: Aug 2000- Aug 2001 ;mandatory internship (clinical training year) with evaluation of Excellent
Internal medicine training at King Saud University;Sep 2001-march 2003.
Internal Medicine residency training at McMasterUniversity; July2003-June2006.
Adult Hematology training program at McMaster University; July 2006- June 2008.
Medical Oncology training program at McMaster University; July 2008-June 2010
Medical oncology fellowship (Lung cancer/Lymphoma) at McMaster University; July 2010-June 2011.
HRM master degree/CIP training at McMaster university July 2009-June 2011.
Languages / I can speak English fluently, beside my tongue-mother language Arabic.
Exams and Boards / I am an ECFMGcertified on 2002.
MRCP(UK) certified,appointed on April 1 , 2004.
LMMC exams, the medical licensing exam for independent practice in Canada, on 2005.
American board of InternalMedicine (certified for the period 2006 through 2016)
Royal College of Physicians and Surgeons board exam in Internal medicine (May 2007)
Royal College of Physicians and Surgeons board exam in Hematology (September 2008)
Royal College of Physicians and Surgeons board exam in Medical Oncology (November 2010)
American Board of Hematology Certified on 2009 (October 2009) scored in the top 90th percentile.
Work experience and present appointments / I have done 18 months of Internal Medicine training in King Khalid University Hospital in Riyadh, Saudi Arabia which is a teaching hospital with an on-site medical schooland functions as tertiary care referral center.
I joined McMasteruniversity Internal medicine residency training program on July 1st, 2003 and completed my training on June 2006.
I have joined the Hematology program on July 1st, 2006and completed my training by June 30th, 2008.
I have joined the Medical Oncology on July 1st, 2008 and completed my training by June 30th, 2010.
Fellowship training in Lung neoplasm and lymphomas for the period July 1,2010 till June 30th,2011
Clinical investigator program (CIP)/ HRM master program at McMaster University July 2009 till June 2011.
Promoted to assistant professor at College of medicine, King Saud University in October ,2011.
Computer Experience / I have a computer experience with the BASIC programming, WORD and PowerPoints and webdesigning.
Nomination/
appreciation / Nominated as one of the best Chief Medical Resident PGY-3
I have received a thanking letter for the Chief of the medical staff for the excellent clinical care for internal medicine service at Henderson Hospital.
Accreditations and licenses / ECFMG (Educational Commission for Foreign Medical Graduates) certified on 2002.
LMCC certification (dated June 17,2005)
MRCP(UK),ABIMand FRCPC certified in Internal Medicine.
FRCPC certified in Hematology, Medical Oncology
ABIM certified in Hematology, Medical Oncology
ACLS instructor certified by Heart and Stroke Foundation of Ontario.
Administrative Experience
References: / Chief Resident, McMaster University Internal Medicine Residency Program, Jan-Mar 2006
Elected hematology resident representative on the educational committee Sep 2006-June 2007
Chief resident,McMaster university Medical Oncology program Apr-June 2009.
Prof. Abdulkareem Al Momen (),
Professor of Medicine & Hematology,King Saud University,
Vice President Saudi Society of Hematology.
Editor-in-Chief,Journl of Applied Hematology,
Dr.Ahmed Al Sagheir ,MBBS, FRCPC ()
Assistant professor of Medicine & Hematology,King Saud University
Hani Al-Hashmi MD,FRCPC()
Consultant Hematologist/medical oncology/BMT , King Fahad specialist Hospital-Dammam.
Publications / Khalid K, Qazi SA, Al-Saleh KA.
Primary actinomycosis of the abdominal wall.
Saudi Med J. 2004 Feb;25(2):229-33.
Lim W, Al Saleh K, Douketis JD.
Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency.
Thromb Res. 2006;118(3):409-16.
Alsaleh KA, Al-Nasser SM, Bates SM, Patel A, Warkentin TE, Arnold DM.
Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis
Am J Hematol. 2008 Aug 19;83(11):876-878
Al-Saleh K, Cindy Quinton, Peter M Ellis “Role of Pemetrexed in Advanced Non-Small Cell Lung Cancer : Meta- analysis of Randomized Controlled Trials with Histology Subgroup Analysis” , accepted for publication in Current Oncology
“Modeling the Length of Stay for an In-patient Malignant Hematology Service Based on Limited Data: a Multilevel Model”. American society of hematology meeting abstracts 2010.